Scientists have engineered a human HIV-1 inhibitor modeled after an owl monkey fusion protein that potently blocks HIV-1 infection. This new treatment showed promise in preventing viral replication in mice and has the potential to be a robust anti-HIV-1 gene therapy candidate.
Scientists have developed a new mouse model of X-linked nephrogenic diabetes insipidus, a severe kidney disease. The model shows that selective EP4 receptor agonists alleviate the symptoms of the disease, suggesting these compounds as potential therapeutics.
Researchers have identified a new mechanism underlying sex-specific gene expression in mice, with PPAR-alpha repressing genes involved in immunity and steroid production. The study also found that this repression is mediated by sumoylation, a process only occurring in female mice, and suggests potential new approaches to prevent estrog...
Researchers discovered that PPAR-alpha's sumoylation process regulates gender-specific gene expression and protects female mice from estrogen-induced liver disease. This finding suggests potential new approaches to prevent this condition by targeting PPAR-alpha agonists.
Researchers developed a simple biological imaging system to visualize live tumor cells in peripheral blood. The technology reflects the tumor burden, decreasing upon primary tumor removal, holding promise for clinical benefit.
Researchers found that Six1 protein is central to tumor development in breast cancer, linked to EMT, stem/progenitor cells, and poor prognosis. Overexpression of Six1 also enhanced ability to metastasize, indicating its role as a key player in aggressive breast cancer.
Researchers identified miR-143 and miR-145 as key regulators of VSMC contractility and blood pressure. The study found that mice lacking these microRNAs had reduced contractile VSMCs and increased tissue matrix-producing cells, leading to signs of blood vessel disease.
Researchers identified a critical crosstalk pathway between lung epithelial cells and airway smooth muscle cells, contributing to lung diseases like asthma and pulmonary hypertension. The study provides potential new therapeutic targets for treating these conditions.
A study found that miR-143 and miR-145 regulate the contractile nature of vascular smooth muscle cells, with their absence leading to increased tissue matrix production and signs of blood vessel disease. The findings suggest these microRNAs could serve as therapeutic targets for enhancing blood vessel repair.
The protein Atf4 plays a crucial role in regulating energy generation in osteoblasts, which control biochemical reactions that produce energy. Mice lacking Atf4 exhibit lower fat mass and blood glucose levels due to increased insulin sensitivity, highlighting the importance of Atf4 in glucose metabolism.
Researchers have identified a new gene, PTRF, which causes mutations leading to muscle weakness and lipodystrophy. The study found that these individuals had deficient caveolin-3 protein in their muscles, despite no mutations in the caveolin-3 gene.
Researchers identified TLR9 expression patterns as a key factor in determining molecule toxicity between mice and humans. In mice, other immune cells expressing TLR9 were responsible for TNF-alpha production, leading to severe lung inflammation and toxicity.
Mutations in the PTRF gene have been found to cause a form of muscular dystrophy with generalized lipodystrophy. The disease is characterized by progressive skeletal muscle weakness and deficiency of caveolin-3 protein.
Researchers have discovered a key link between protein CCKR2 and progastrin-related colonic hyperproliferation. Deletion of the Cck2r gene in mice with human progastrin overexpression abolished colonic hyperproliferation and reduced colorectal cancer, suggesting CCKR2 as a viable target for treatment.
Researchers at Children's Hospital of Philadelphia have identified an immune mechanism responsible for graft failure in a mouse model of IUHCT. Maternal alloantibodies, produced in response to IUHCT, trigger a postnatal immune response that limits engraftment following in utero hematopoietic cell transplantation. This finding opens the...
Researchers found that fetal immune cells eliminate transplanted allogeneic blood cells, but only triggered by maternal breast milk antibodies. This limits engraftment following in utero hematopoietic cell transplantation.
A new study reveals that Sirt3 helps protect the mouse heart by blocking cardiac hypertrophic response through Foxo3a-dependent antioxidant defense mechanisms. Mice lacking Sirt3 developed enlarged hearts, while those overexpressing Sirt3 were protected from cardiac hypertrophy under similar conditions.
A new gene, RCP, has been identified as a potential breast cancer-promoting gene, with overexpression causing tumor cell characteristics and metastasis. Targeting RCP may provide a way to inhibit the known tumor-promoting pathway through activation of the RAS signaling pathway.
Researchers at Yale University School of Medicine and the University of California Davis have discovered a protein, PRCP, that regulates appetite suppression by breaking down alpha-MSH in mice. Administration of PRCP inhibitors reduced food intake in both normal and obese mice.
A team of researchers has identified a protein that breaks down an appetite-suppressing peptide, leading to reduced food intake in mice. Mice lacking the protein were leaner and less likely to become obese on high-fat diets.
A team of researchers has found that transplanting sheets of clonally expanded heart cells improves heart function after a heart attack in mice. The cells secreted a molecule that induced the migration of endothelial cells and prevented oxidative stress, leading to improved heart function.
Researchers found that inhibiting Nox4 substantially inhibits hemangioma growth in a mouse model, while transplantation of cardiac progenitor cells improves heart function after myocardial infarction. Additionally, IL-17 and IL-22 play a crucial role in protecting individuals from developing kala azar, a lethal parasite disease.
Researchers have identified protein Nox4 as crucial for hemangioma growth and found a potent inhibitor fulvene-5 to substantially inhibit its growth. This discovery suggests targeting Nox4 using fulvene derivatives may attenuate hemangioma growth.
Researchers identified CST5 as a candidate tumor suppressor gene induced by vitamin D3 in human colon cancer cells. The protein cystatin D inhibits cancer cell growth and is responsible for some of vitamin D3's anticancer effects.
Researchers have identified a potential tumor suppressor gene, CST5, that mediates the anticancer effects of vitamin D3 in human colon cancer cells. The study found that cystatin D protein inhibited the growth of colon cancer cells and was induced by vitamin D3, suggesting its role as a candidate tumor suppressor gene.
Researchers have found that the circadian clock protein Period 1 regulates expression of the renal epithelial sodium channel in mice, leading to decreased sodium loss in urine. Additionally, a study on gene therapy revealed that TLR9-MyD88 pathway is critical for adaptive immune responses to AAV vectors. Another study on kidney repair ...
Researchers found that Period 1 regulates expression of alpha-ENaC in mouse kidney, leading to decreased sodium loss in urine. The study suggests a link between the circadian rhythm and salt balance, with implications for blood pressure control.
Researchers identified Gpx5 as a protective protein for immature sperm in the epididymis, reducing oxidative stress and associated with improved fertility outcomes. In contrast, males lacking Gpx5 showed increased miscarriage rates and fetal developmental defects.
A study found that the Gpx5 protein helps protect immature mouse sperm from oxidative stress, which is associated with fertility issues and miscarriages. In contrast, high levels of IL-21 are linked to an increased risk of developing autoimmune diseases in multiple sclerosis patients treated with alemtuzumab.
Researchers have developed a gene delivery approach to target therapeutic genes to nerves in the dorsal root ganglion (DRG), a region affected in various sensory neuronopathies. This method, using helper-dependent adenoviruses, was found to be more efficient at delivering genes to DRG nerves compared to nontargeted versions.
Researchers at Baylor College of Medicine have developed a system to target therapeutic genes to nerves in the dorsal root ganglion (DRG), showing dramatic efficiency in gene delivery compared to nontargeted adenoviruses. In mice lacking the Hexb gene, administration of DRG-targeted helper-dependent adenoviruses carrying the Hexb gene ...
Researchers at the University of Minnesota Medical School have successfully provided long-term expression of Factor VIII in hemophilia A mice using a new gene therapy approach, marking a promising step toward human clinical trials.
Researchers develop gene therapy approach to target Factor VIII in hemophilia A mice, reducing disease symptoms. L-Asparaginase degradation mechanism also uncovered, with potential for optimizing treatment.
Researchers identified a protein capable of degrading a key leukemia treatment, L-asparaginase, in some patients. Expression of this protein is more common in high-risk forms of the disease and can lead to reduced treatment effectiveness.
Researchers have identified a mechanism by which influenza virus makes individuals more susceptible to secondary bacterial pneumonia. Type I IFNs, key mediators of the antiviral immune response, impair the ability to mount an adequate immune response to subsequent pneumonia-causing bacterial infection.
Researchers identified a way to boost cisplatin's effectiveness by targeting DNA repair proteins in cancer cells. Attenuating the function of RAD50 protein complex sensitizes human tumor cells to cisplatin-based chemotherapy.
A study in mice reveals that type I IFNs compromise the body's ability to mount an effective immune response against bacterial infections after influenza. This finding may lead to new avenues for developing treatments to combat post-influenza bacterial pneumonia.
Research reveals ILK promotes growth in aggressive ARMS cells, while suppressing ERMS cell growth. Targeting ILK may offer therapeutic strategy for ARMS patients.
Researchers have identified the protein ILK as promoting growth of aggressive rhabdomyosarcoma cells and suppressing ERMS cell growth. A therapy targeting ILK may provide a tailored approach for treating the lethal form of RMS, ARMS.
Researchers found that glucocorticoids induce production of PGD2, which protects rodent hearts from ischemia/reperfusion injury. Synthetic glucocorticoids may be more beneficial for humans following a heart attack than traditional ones.
Researchers have identified a molecular link between sleep and weight gain, suggesting that targeting T-type calcium channels could be beneficial for weight loss. Additionally, studies on glucocorticoid hormones have revealed their protective effects on the heart during ischemia/reperfusion injury.
Researchers found T-type calcium channels regulate body weight and sleep, suggesting a link between the two. Mice lacking these channels were resistant to weight gain on high-fat diets.
LXRs play a protective role against Mycobacterium tuberculosis infection by boosting Th1 and Th17 immune responses. Treatment with LXR activators provides substantial protection from infections.
Researchers identified LXR proteins as a new target in the fight against tuberculosis, providing substantial protection against infection. Additionally, studies revealed that immune cells can destroy AAV-transduced liver cells through CTL recognition, suggesting a potential therapeutic intervention to improve gene therapy success.
Researchers have identified a protein responsible for regulating branched-chain amino acid catabolism, which may be linked to Maple Syrup Urine Disease. Additionally, immune cells called V-alpha-24-invariant NKT cells can indirectly affect neuroblastoma growth by killing tumor-associated cells that promote its growth.
Researchers identified CEACAM6 as a key factor blocking the effectiveness of adenovirus-based therapies in treating cancer. Knocking down CEACAM6 expression increased anticancer effects in mice with human tumor cells.
A team of researchers developed an antibody targeting FGFR3, which showed potent antitumor activity against human bladder cancer cells and t(4;14)-positive multiple myeloma cells. The antibody also demonstrated activity against normal FGFR3 and mutated forms associated with cancer.
A study found that consuming fructose-sweetened beverages increased intraabdominal fat and decreased insulin sensitivity, while glucose-sweetened beverages had no significant effects. This suggests that fructose may be more detrimental to health than glucose.
A study found that consuming fructose-sweetened beverages increases visceral adiposity and lipids while decreasing insulin sensitivity in overweight/obese humans. This increase in heart attack susceptibility remains unknown due to long-term effects of fructose over-consumption.
A study by Steffen Stenger and colleagues found that anti-TNF therapies, such as infliximab, decrease the immune system's ability to fight infections, including tuberculosis. The researchers identified a key immune cell subset, CD45RA+ effector memory CD8+ T cells, which plays a major role in targeting the bacterium that causes TB.